Home Cart Sign in  
Chemical Structure| 1004-38-2 Chemical Structure| 1004-38-2

Structure of 1004-38-2

Chemical Structure| 1004-38-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1004-38-2 ]

CAS No. :1004-38-2
Formula : C4H7N5
M.W : 125.13
SMILES Code : C1=C(N=C(N=C1N)N)N
MDL No. :MFCD00006100
InChI Key :JTTIOYHBNXDJOD-UHFFFAOYSA-N
Pubchem ID :13863

Safety of [ 1004-38-2 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 1004-38-2 ] Show Less

Physicochemical Properties

Num. heavy atoms 9
Num. arom. heavy atoms 6
Fraction Csp3 0.0
Num. rotatable bonds 0
Num. H-bond acceptors 2.0
Num. H-bond donors 3.0
Molar Refractivity 35.25
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

103.84 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.41
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

-0.84
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

-0.75
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-1.87
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.08
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

-0.83

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-0.58
Solubility 32.9 mg/ml ; 0.263 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-0.86
Solubility 17.3 mg/ml ; 0.138 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.53
Solubility 36.7 mg/ml ; 0.293 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

Yes
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.66 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

2.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.89

Application In Synthesis of [ 1004-38-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1004-38-2 ]

[ 1004-38-2 ] Synthesis Path-Downstream   1~35

  • 1
  • [ 3764-01-0 ]
  • [ 1004-38-2 ]
  • 2
  • [ 3764-01-0 ]
  • [ 1004-38-2 ]
  • [ 156-83-2 ]
  • 3
  • [ 1004-38-2 ]
  • [ 87-39-8 ]
  • [ 7147-37-7 ]
  • 4
  • [ 1004-38-2 ]
  • [ 14848-68-1 ]
  • [ 20739-02-0 ]
  • 5
  • [ 1004-38-2 ]
  • [ 51673-62-2 ]
  • [ 20738-97-0 ]
  • 6
  • [ 1004-38-2 ]
  • [ 15511-25-8 ]
  • [ 32524-43-9 ]
  • 7
  • [ 1004-38-2 ]
  • [ 27970-85-0 ]
  • [ 20739-08-6 ]
  • 8
  • [ 1004-38-2 ]
  • [ 10327-01-2 ]
  • [ 17752-59-9 ]
  • 9
  • [ 1004-38-2 ]
  • [ 56856-73-6 ]
  • [ 20739-00-8 ]
  • 10
  • [ 1004-38-2 ]
  • [ 333-20-0 ]
  • [ 30162-01-7 ]
  • 11
  • [ 1004-38-2 ]
  • [ 100-34-5 ]
  • [ 2227-25-0 ]
  • 12
  • [ 1004-38-2 ]
  • [ 108-24-7 ]
  • <i>N</i>,<i>N</i>',<i>N</i>''-pyrimidine-2,4,6-triyl-tris-acetamide [ No CAS ]
  • 13
  • [ 1004-38-2 ]
  • [ 120-46-7 ]
  • [ 20732-44-9 ]
  • 14
  • [ 1004-38-2 ]
  • [ 123-54-6 ]
  • [ 20739-23-5 ]
  • 15
  • [ 1004-38-2 ]
  • [ 15397-33-8 ]
  • [ 19181-38-5 ]
  • 16
  • [ 1004-38-2 ]
  • [ 14377-02-7 ]
  • [ 97619-36-8 ]
  • 18
  • [ 1004-38-2 ]
  • [ 18620-97-8 ]
  • 19
  • [ 1004-38-2 ]
  • [ 24867-36-5 ]
YieldReaction ConditionsOperation in experiment
94% With nitric acid; In acetic anhydride; at 15℃; for 3h; (1) At 15C, 6 ml of fuming nitric acid was slowly added dropwise to 6 ml of acetic anhydride. 2g (16 mmol) of <strong>[1004-38-2]2,4,6-triaminopyrimidine</strong> was added to the mixed acid in several batches. After the addition, the reaction was completed. The system was reacted at this temperature for 3 h. The reaction solution was poured into ice water, and the solid was suction filtered and dried to obtain 2,4,6-triamino-5-nitropyrimidine in a yield of 94%
  • 22
  • [ 1004-38-2 ]
  • [ 67209-10-3 ]
  • [ 67209-16-9 ]
  • 23
  • [ 2579-22-8 ]
  • [ 1004-38-2 ]
  • [ 19181-38-5 ]
  • 24
  • [ 2579-22-8 ]
  • [ 1004-38-2 ]
  • [ 19181-34-1 ]
  • 25
  • [ 1201-93-0 ]
  • [ 1004-38-2 ]
  • [ 19181-38-5 ]
  • 26
  • [ 2740-83-2 ]
  • [ 1004-38-2 ]
  • [ 50-00-0 ]
  • [ 79988-63-9 ]
  • 27
  • [ 1004-38-2 ]
  • [ 50-00-0 ]
  • [ 13078-80-3 ]
  • [ 79988-70-8 ]
  • [ 79988-64-0 ]
  • 28
  • [ 1004-38-2 ]
  • [ 50-00-0 ]
  • [ 14573-23-0 ]
  • [ 79988-70-8 ]
  • [ 79988-69-5 ]
  • 29
  • [ 1004-38-2 ]
  • [ 50-00-0 ]
  • [ 52516-13-9 ]
  • [ 79988-70-8 ]
  • [ 79988-68-4 ]
  • 30
  • [ 1004-38-2 ]
  • [ 50-00-0 ]
  • [ 38936-60-6 ]
  • [ 85661-12-7 ]
  • 31
  • [ 1004-38-2 ]
  • [ 50-00-0 ]
  • [ 15256-07-2 ]
  • [ 85661-15-0 ]
  • 32
  • [ 1004-38-2 ]
  • [ 50-00-0 ]
  • [ 52516-30-0 ]
  • [ 79988-70-8 ]
  • [ 79988-67-3 ]
  • 33
  • [ 1004-38-2 ]
  • [ 50-00-0 ]
  • O-[2-(4-Chloro-phenyl)-ethyl]-hydroxylamine; hydrochloride [ No CAS ]
  • [ 85661-16-1 ]
  • 34
  • [ 1004-38-2 ]
  • [ 50-00-0 ]
  • [ 1885-52-5 ]
  • [ 85661-14-9 ]
  • 35
  • [ 1004-38-2 ]
  • [ 50-00-0 ]
  • [ 51572-93-1 ]
  • [ 85661-13-8 ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 1004-38-2 ]

Amines

Chemical Structure| 2434-56-2

A143419 [2434-56-2]

4,6-Diaminopyrimidine

Similarity: 0.90

Chemical Structure| 1791-73-7

A377738 [1791-73-7]

6-Methyl-2,4-pyrimidinediamine

Similarity: 0.79

Chemical Structure| 591-54-8

A145044 [591-54-8]

4-Aminopyrimidine

Similarity: 0.76

Chemical Structure| 157924-46-4

A114506 [157924-46-4]

5-Iodopyrimidine-2,4-diamine

Similarity: 0.75

Chemical Structure| 109-12-6

A142818 [109-12-6]

Pyrimidin-2-amine

Similarity: 0.73

Related Parent Nucleus of
[ 1004-38-2 ]

Pyrimidines

Chemical Structure| 2434-56-2

A143419 [2434-56-2]

4,6-Diaminopyrimidine

Similarity: 0.90

Chemical Structure| 1791-73-7

A377738 [1791-73-7]

6-Methyl-2,4-pyrimidinediamine

Similarity: 0.79

Chemical Structure| 591-54-8

A145044 [591-54-8]

4-Aminopyrimidine

Similarity: 0.76

Chemical Structure| 157924-46-4

A114506 [157924-46-4]

5-Iodopyrimidine-2,4-diamine

Similarity: 0.75

Chemical Structure| 109-12-6

A142818 [109-12-6]

Pyrimidin-2-amine

Similarity: 0.73